Additional file 1: Table S1. Patient characteristics of train groups (supplement data). Table S2. Patient Characteristics of train groups. Table S3. Patient characteristics of the validation groups. T
2.6% of pancreatic cancer patients have the primary manifestation of gastrointestinal bleeding. It is not feasible to stop the duodenal hemorrhage caused by the pancreatic cancer infiltration. A 43-ye
The goal is to analyze the impact of chemotherapy drug busulfan on spermatogonia Overall design: 18 samples, either 5 or 4 replicates per condition, controls are DMSO treated cells
